Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
Sign in to your account